Posts in category Insights


Canaccord Slashes Price Target for Versartis Inc to $9.00 as GHD Drug Flunks Phase 3 Trial

Could Versartis recover after today’s big decline?

Read more

Kenneth Herbert Shares Two Cents on Kratos Defense & Security Solutions, Inc (KTOS) Following Investor Meetings with Management

A glimpse into recent investor meetings with management of Kratos Defense & Security.

Read more

Ask Analysts: Where Versartis Inc (VSAR), Ascendis Pharma A/S (ASND) Stocks Are Heading from Here?

A ‘game over’ for Versartis’ somavaratan; A powerful boost for Ascendis’ TC-hGH.

Read more

Wall Street Doesn’t Understand That Walt Disney Co (DIS) Is the Best Long-Term Play in the Space, Says Wells Fargo

Thanks to a built-in marketing machine, the analyst believes new DIS streaming service will benefit.

Read more

Cantor Asserts That Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Loan Amendments Get Rid of Meaningful Overhang on Stock

Analyst says share weakness does not stem from encouraging news, but points to other underlying concerns.

Read more

Drexel Hamilton Believes Apple Inc.’s (AAPL) iPhone X Is Poised to Become the Pinnacle of the Smartphone Market

Analyst praises Apple’s creative finesse at being able to separate itself from the rest of its rivals.

Read more

Netflix, Inc. (NFLX) Could Attain High Range of Up to 90 Million Target Domestic Subscribers by 2025; Moffett-Nathanson Lifts Price Target

Analyst notes that regardless of which content is garnering Netflix’s viewers, subscribers keep joining.

Read more

Supernus Pharmaceuticals Inc (SUPN) Investors Are Scared Off by Elimination of Low SPN-810 Dose; Cantor Makes a Bullish Case

Supernus investors are running for the hills, but analyst sees elimination of 18 mg dose as a good move.

Read more

Is it Time to Raise a White Flag on Nike Inc (NKE)? Canaccord Reigns in Expectations for Fiscal 2018

How long will investors still hold out patience for Nike after two years of a “stale innovation pipeline?”

Read more

Another Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Divestiture? Cantor Says Women’s Health Franchise Sale Could Drive Share Appreciation

Though Teva shares took a hit upon the news, the analyst sees an upside to expectations in the distance.

Read more